Immix Biopharma Inc — Quarterly Financial Statistics (NASDAQ:IMMX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities -4.04 M-1.48 M-1.69 M-5.31 M-5.91 M -14.38 M Cash from investing activities -271.54 K-507.15 K-67.71 K-127.63 K-372.46 K -1.07 M Cash from financing activities 0001.11 M10.61 M 11.72 M Free cash flow -4.31 M-1.98 M-1.75 M-5.44 M-6.28 M -15.45 M

新闻

Immix Biopharma股价上涨，FDA授予突破性疗法地位

FDA授予ImmixBio淀粉样变性药物突破性疗法地位

Immix Biopharma stock climbs after FDA grants breakthrough therapy status

FDA grants breakthrough therapy status to ImmixBio’s amyloidosis drug

Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities - Immix Biopharma (NASDAQ:IMMX)

Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition (IMMX)

Immix Biopharma首席财务官Gabriel Morris购入价值5千美元股票

Immix Biopharma首席执行官Ilya Rachman购入价值$4,975股票

Immix Biopharma CFO Gabriel Morris buys $5k in shares

Ilya Rachman, Immix Biopharma CEO, buys $4975 in shares

H.C. Wainwright将Immix Biopharma目标价从8美元上调至12美元

Immix Biopharma stock price target raised to $12 from $8 at H.C. Wainwright